Cargando…

Gene therapy and genome editing for primary immunodeficiency diseases

In past two decades the gene therapy using genetic modified autologous hematopoietic stem cells (HSCs) transduced with the viral vector has become a promising alternative option for treating primary immunodeficiency diseases (PIDs). Despite of some pitfalls at early stage clinical trials, the field...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhi-Yong, Thrasher, Adrian J., Zhang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063425/ https://www.ncbi.nlm.nih.gov/pubmed/32181274 http://dx.doi.org/10.1016/j.gendis.2019.07.007

Ejemplares similares

Gene Editing for the Treatment of Primary Immunodeficiency Diseases
por: Rai, Rajeev, et al.
Publicado: (2021)

Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease
por: Blanco, Elena, et al.
Publicado: (2020)

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency
por: Abdul-Razak, H. H., et al.
Publicado: (2018)

Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies
por: Ott de Bruin, Lisa M., et al.
Publicado: (2015)

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
por: Montiel-Equihua, Claudia A, et al.
Publicado: (2009)

Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
por: Eguizabal, C., et al.
Publicado: (2020)

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
por: Poletti, Valentina, et al.
Publicado: (2018)

Genome editing for blood disorders: state of the art and recent advances
por: Romito, Marianna, et al.
Publicado: (2019)

Gene Editing and Genotoxicity: Targeting the Off-Targets
por: Blattner, Georges, et al.
Publicado: (2020)

Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
por: Eguizabal, C., et al.
Publicado: (2021)

Gene Therapy for Primary Immunodeficiency
por: Houghton, Benjamin C., et al.
Publicado: (2020)

Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
por: Naseem, Asma, et al.
Publicado: (2022)

Actin cytoskeletal defects in immunodeficiency
por: Moulding, Dale A, et al.
Publicado: (2013)

Advances of gene therapy for primary immunodeficiencies
por: Candotti, Fabio
Publicado: (2016)

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
por: Alzubi, Jamal, et al.
Publicado: (2017)

Gene therapy: progress and predictions
por: Collins, Mary, et al.
Publicado: (2015)

Whole genome sequencing of a sporadic primary immunodeficiency cohort
por: Thaventhiran, James E. D., et al.
Publicado: (2020)

Applications of Genome Editing Technology in Animal Disease Modeling and Gene Therapy
por: Li, Qian, et al.
Publicado: (2019)

Gene therapy for PIDs: Progress, pitfalls and prospects
por: Mukherjee, Sayandip, et al.
Publicado: (2013)

Genome-editing Technologies for Gene and Cell Therapy
por: Maeder, Morgan L, et al.
Publicado: (2016)

Wiskott–Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation
por: Bouma, Gerben, et al.
Publicado: (2009)

Tailored therapies for primary immunodeficiencies
por: Cinicola, Bianca, et al.
Publicado: (2021)

Gene therapy for Whiskott–Aldrich syndrome: The latest news
por: Cavazzana, Marina, et al.
Publicado: (2022)

An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
por: Rai, Rajeev, et al.
Publicado: (2023)

Gene analysis of seven cases of primary immunodeficiency
por: Zhu, Ying, et al.
Publicado: (2020)

Primary Immunodeficiency Diseases
por: Baltimore, Robert S.
Publicado: (1984)

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015)

Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter
por: Chandra, Anita, et al.
Publicado: (2016)

Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing
por: Hou, Yujuan, et al.
Publicado: (2022)

CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome
por: Ravendran, Sujan, et al.
Publicado: (2022)

Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
por: Raikwar, Sudhanshu P., et al.
Publicado: (2018)

Primary immunodeficiency diseases in the newborn
por: Ozdemir, Oner
Publicado: (2021)

Genes at the Crossroad of Primary Immunodeficiencies and Cancer
por: Derpoorter, Charlotte, et al.
Publicado: (2018)

Genome-Edited T Cell Therapies
por: Delhove, Juliette M. K. M., et al.
Publicado: (2017)

Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
por: Maule, Giulia, et al.
Publicado: (2020)

Moving toward genome-editing therapies for cardiovascular diseases
por: Musunuru, Kiran
Publicado: (2022)

Primary Immunodeficiencies
Publicado: (2008)

Genome-editing technologies for gene correction of hemophilia
por: Park, Chul-Yong, et al.
Publicado: (2016)

Current Perspectives on Primary Immunodeficiency Diseases
por: Kumar, Arvind, et al.
Publicado: (2006)

History of Primary Immunodeficiency Diseases in Iran
por: Aghamohammadi, Asghar, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o060n03cipsd4pipbe58p8tl9b